At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...